Article Text

Download PDFPDF
Uncommon obstacle: management of end-stage heart failure in thrombocytopenia with absent radii (TAR) syndrome
  1. Jean Kim1,
  2. Jakrin Kewcharoen1,
  3. Corey J Lum2 and
  4. Steven S Azuma3
  1. 1Department of Internal Medicine, University of Hawai'i System, Honolulu, Hawaii, USA
  2. 2Queen's Heart Institute, Queen's Medical Center, Honolulu, Hawaii, USA
  3. 3Department of Cardiovascular Disease, Kuakini Medical Center, Honolulu, Hawaii, USA
  1. Correspondence to Dr Jean Kim; jeankim{at}


Thrombocytopenia with absent radii (TAR) syndrome is a rare genetic condition causing absent radial bones and thrombocytopenia. Management is generally supportive although there may be a role for platelet-stimulating agents such as romiplostim. In this case, we highlight the obstacles in managing end-stage heart failure in a patient with TAR syndrome.

  • heart failure
  • cardiovascular system
  • haematology (incl blood transfusion)

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors JKi conceptualised, designed and wrote the case report. JKe, CJL and SSA revised the report critically for important intellectual content. All authors approved of the final version.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.